Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,904 | 613 | 99.1% |
| Education | $94.41 | 8 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,826 | 101 | $0 (2024) |
| Novo Nordisk Inc | $1,077 | 67 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $959.53 | 64 | $0 (2024) |
| Lilly USA, LLC | $933.04 | 56 | $0 (2024) |
| GlaxoSmithKline, LLC. | $601.76 | 37 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $599.17 | 65 | $0 (2022) |
| Merck Sharp & Dohme LLC | $500.73 | 31 | $0 (2023) |
| PFIZER INC. | $416.40 | 30 | $0 (2024) |
| Amgen Inc. | $369.33 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $338.21 | 20 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,457 | 71 | AstraZeneca Pharmaceuticals LP ($433.23) |
| 2023 | $1,342 | 69 | AstraZeneca Pharmaceuticals LP ($339.61) |
| 2022 | $1,406 | 83 | AstraZeneca Pharmaceuticals LP ($211.59) |
| 2021 | $1,334 | 83 | Boehringer Ingelheim Pharmaceuticals, Inc. ($177.58) |
| 2020 | $657.72 | 40 | AstraZeneca Pharmaceuticals LP ($119.32) |
| 2019 | $1,023 | 73 | AstraZeneca Pharmaceuticals LP ($206.63) |
| 2018 | $1,184 | 91 | Janssen Pharmaceuticals, Inc ($229.30) |
| 2017 | $1,594 | 111 | Lilly USA, LLC ($234.81) |
All Payment Transactions
621 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: DIABETES | ||||||
| 12/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Oncology | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $86.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Endocrinology | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: VACCINES | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Endocrinology | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardiology | ||||||
| 08/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: DIABETES | ||||||
| 08/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Obesity | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 962 | 1,346 | $153,034 | $86,593 |
| 2022 | 15 | 1,254 | 1,661 | $166,912 | $97,473 |
| 2021 | 14 | 1,260 | 1,611 | $153,774 | $90,268 |
| 2020 | 16 | 1,363 | 1,708 | $159,575 | $80,376 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 208 | 360 | $57,600 | $27,527 | 47.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 179 | 179 | $28,640 | $21,641 | 75.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 163 | 356 | $42,720 | $20,957 | 49.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $3,190 | $3,092 | 96.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 57 | 80 | $5,200 | $2,765 | 53.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 18 | 18 | $3,600 | $2,722 | 75.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 16 | $4,000 | $2,426 | 60.6% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 58 | 58 | $1,972 | $1,933 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 57 | 57 | $1,425 | $1,397 | 98.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 45 | 45 | $900.00 | $755.10 | 83.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 56 | 61 | $2,257 | $568.70 | 25.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $330.00 | $317.90 | 96.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 29 | 31 | $465.00 | $248.43 | 53.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 33 | 33 | $495.00 | $141.57 | 28.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 24 | 30 | $240.00 | $102.30 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 227 | 389 | $62,240 | $30,744 | 49.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 193 | 193 | $30,880 | $24,001 | 77.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 181 | 357 | $42,840 | $20,778 | 48.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 70 | 120 | $7,800 | $4,205 | 53.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 204 | 204 | $4,080 | $3,532 | 86.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $3,150 | $3,018 | 95.8% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 94 | 94 | $3,196 | $2,968 | 92.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 16 | 17 | $4,250 | $2,651 | 62.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 94 | 94 | $2,350 | $2,305 | 98.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $2,200 | $1,760 | 80.0% |
About Dr. Jack Kinder, M.D
Dr. Jack Kinder, M.D is a Internal Medicine healthcare provider based in Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831199959.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Kinder, M.D has received a total of $9,999 in payments from pharmaceutical and medical device companies, with $1,457 received in 2024. These payments were reported across 621 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($9,904).
As a Medicare-enrolled provider, Kinder has provided services to 4,839 Medicare beneficiaries, totaling 6,326 services with total Medicare billing of $354,711. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Charleston, WV
- Active Since 07/29/2005
- Last Updated 01/19/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1831199959
Products in Payments
- FARXIGA (Drug) $697.74
- Ozempic (Drug) $545.19
- JARDIANCE (Drug) $459.18
- XARELTO (Drug) $457.78
- BREZTRI (Drug) $420.06
- TRADJENTA (Drug) $404.69
- TRULICITY (Drug) $324.86
- SHINGRIX (Biological) $301.33
- JANUVIA (Drug) $299.57
- Vascepa (Drug) $285.38
- AIRSUPRA (Drug) $266.59
- Rybelsus (Drug) $224.32
- BEVESPI AEROSPHERE (Drug) $192.44
- UBRELVY (Drug) $190.12
- ENTRESTO (Drug) $186.08
- SOLIQUA 100/33 (Biological) $184.02
- ELIQUIS (Drug) $172.88
- QUVIVIQ (Drug) $152.24
- SYMBICORT (Drug) $141.54
- VOQUEZNA (Drug) $137.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charleston
William Chapman, Do, DO
Internal Medicine — Payments: $1.3M
Dr. Ryan Tedford, M.d, M.D
Internal Medicine — Payments: $432,170
Harold Szerlip, Md, MD
Internal Medicine — Payments: $284,278
Dr. Nathan Shores, M.d, M.D
Internal Medicine — Payments: $262,570
Hamza Hashmi, M.d, M.D
Internal Medicine — Payments: $234,146
Dr. Anne Kroman, D.o., Phd, D.O., PHD
Internal Medicine — Payments: $202,518